HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoxia Su Selected Research

Thioredoxins

1/2021Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoxia Su Research Topics

Disease

7Osteoporosis
01/2023 - 01/2016
3Neoplasms (Cancer)
08/2023 - 01/2021
3Colitis
01/2018 - 01/2016
2Inflammation (Inflammations)
01/2023 - 01/2017
2Bone Diseases (Bone Disease)
01/2022 - 01/2022
1Appendicitis
01/2024
1Coinfection
10/2023
1Wilms Tumor (Wilm's Tumor)
08/2023
1Alveolar Bone Loss
01/2023
1Intussusception
01/2023
1Bone Resorption
12/2022
1Echinococcosis (Hydatid Cysts)
01/2022
1Hepatic Echinococcosis
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Periodontitis
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Non-alcoholic Fatty Liver Disease
01/2021
1Orthostatic Hypotension (Postural Hypotension)
01/2020
1Arteriovenous Fistula
10/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017
1Weight Loss (Weight Reduction)
01/2017
1Embolism (Embolus)
01/2017
1Thrombosis (Thrombus)
01/2017

Drug/Important Bio-Agent (IBA)

5Therapeutic UsesIBA
01/2023 - 01/2016
3MicroRNAs (MicroRNA)IBA
12/2022 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2020
2butaselenIBA
01/2023 - 01/2021
2Thioredoxin-Disulfide ReductaseIBA
01/2023 - 01/2021
2Histones (Histone)IBA
01/2022 - 01/2018
2AntioxidantsIBA
01/2021 - 04/2016
1C-Reactive ProteinIBA
01/2024
1Prealbumin (Transthyretin)IBA
01/2024
1Antiviral Agents (Antivirals)IBA
10/2023
1DeoxyuridineIBA
08/2023
1Circular RNAIBA
08/2023
12-furoyl-LIGRLO-amideIBA
01/2023
1SaltsIBA
01/2023
1hyperosideIBA
01/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
1Trifluoroacetic Acid (Trifluoroacetate)IBA
01/2023
1CateninsIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1matrigelIBA
01/2022
1Nanoparticle Drug Delivery SystemIBA
01/2022
1Albendazole (Albenza)FDA Link
01/2022
1SeleniumIBA
01/2021
1SilymarinIBA
01/2021
1ThioredoxinsIBA
01/2021
1CollagenIBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1Serum AlbuminIBA
01/2020
1Hypnotics and Sedatives (Sedatives)IBA
01/2020
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2018
1human KAT2A proteinIBA
10/2017
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2017
1Heparin (Liquaemin)FDA LinkGeneric
01/2017
1Estrogens (Estrogen)FDA Link
04/2016
1MelatoninIBA
01/2016

Therapy/Procedure

8Therapeutics
01/2023 - 01/2016
2Immunotherapy
01/2023 - 01/2016
1Enema (Enemas)
01/2023
1Aftercare (After-Treatment)
01/2023
1Contraindications
01/2022
1Hepatectomy
01/2022
1Liver Transplantation
01/2022
1Intraperitoneal Injections
01/2021
1Oral Administration
01/2021
1Renal Dialysis (Hemodialysis)
10/2018
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2017